Ketone body effects on Network stability and Resilience in Humans (KeNeReHum): study protocol for a single-center, randomized, double-blind, crossover trial in healthy adults
Abstract Background: Stress is a major risk factor for psychiatric disorders, including depression and anxiety. Resilience, the maintenance of mental health despite stressor exposure, varies substantially between individuals, yet the neurobiological mechanisms remain poorly understood. Emerging evidence links stress-related psychopathology to metabolic dysregulation such as hyperglycemia and insulin resistance, suggesting shared underlying mechanisms. Resting-state brain network stability has been associated with preserved cognitive acuity and can be modulated by metabolic factors. The ketone body β-hydroxybutyrate (BHB), produced endogenously during fasting and ketogenic diets, has been shown to enhance brain network stability in young adults compared to glucose. However, the relationships between individual resilience capacity, baseline network properties, and metabolic responsiveness remains unknown. Methods: This monocentric, randomized, double-blind crossover trial will recruit 60 healthy adults (20–45 years) from the Longitudinal Resilience Assessment (LORA) cohort, which provides outcome-based resilience measures (stressor reactivity scores) from 5-8 years of longitudinal assessments. Participants will receive a single oral dose of BHB monoester (395 mg/kg) and a calorically matched glucose solution on two separate visits, with the order randomized 1:1. At baseline on both visits, resting-state functional MRI (rs-fMRI) and arterial spin labeling (ASL) will be performed to assess brain network stability and blood-brain barrier permeability. Following ingestion, rs-fMRI will be repeated 30 minutes post-dose to capture acute metabolic effects. The primary outcome is the difference in brain network stability between BHB and glucose conditions. Secondary outcomes examine whether individual differences in resilience moderate these metabolic effects and relate to baseline network and blood-brain barrier measures. Discussion: This study uniquely combines an acute metabolic challenge with longitudinal resilience phenotyping to test whether brain network stability and blood-brain barrier function are associated with resilience. The availability of outcome-based resilience measures allows direct examination of whether individual differences in resilience relate to baseline network properties and metabolic responsiveness. If confirmed, findings could inform mechanistic models linking metabolism, neural dynamics, and stress resilience, and guide development of novel metabolic intervention strategies to promote resilience and prevent stress-related disorders. Trial registration: The study is registered in the German Clinical Trials Register (DRKS), DRKS00038898. Registered 12 January 2026.
Authors
- Alexandra Sebastian (ORCID: https://orcid.org/0000-0002-8381-8312)
- Annika Hasch
- Raffaël Kalisch (ORCID: https://orcid.org/0000-0002-9503-7601)
- Florian Müller‐Dahlhaus (ORCID: https://orcid.org/0000-0003-2861-7363)
- Daniel Turner (ORCID: https://orcid.org/0000-0003-3038-6103)
- Julia Guldan
- Oliver Tüscher (ORCID: https://orcid.org/0000-0002-4023-5301)
- Florian U. Fischer
Institutions
- Leibniz Institute for Resilience Research (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-8678908/v1
- Primary Topic
- Diet and metabolism studies
- Type
- preprint